Condensed Consolidating Financial Statements of Aramark and Subsidiaries | CONDENSED CONSOLIDATING FINANCIAL STATEMENTS OF ARAMARK AND SUBSIDIARIES: The following condensed consolidating financial statements of the Company have been prepared pursuant to Rule 3-10 of Regulation S-X. The condensed consolidating financial statements are presented for: (i) Aramark (the "Parent"); (ii) ASI and Aramark International Finance S.à.r.l. (the "Issuers"); (iii) the guarantors; (iv) the non guarantors; (v) elimination entries necessary to consolidate the Parent with the Issuers, the guarantors and non guarantors; and (vi) the Company on a consolidated basis. Each of the guarantors is wholly-owned, directly or indirectly, by the Company. The 5.125% Senior Notes due 2024 (the "2024 Notes"), 5.000% Senior Notes due April 1, 2025 (the "5.000% 2025 Notes"), 3.125% Senior Notes due April 1, 2025 (the " 3.125% 2025 Notes" and, together with the 5.000% 2025 Notes, the "2025 Notes"), 4.75% Senior Notes due June 1, 2026 ("2026 Notes") and 5.000% Senior Notes due February 1, 2028 (the "2028 Notes") are obligations of the Company's wholly-owned subsidiary, ASI, (other than the 3.125% 2025 Notes, which are obligations of the Company's wholly owned subsidiary, Aramark International Finance S.a.r.l) and are each jointly and severally guaranteed on a senior unsecured basis by the Company and substantially all of the Company's existing and future domestic subsidiaries (excluding the Receivables Facility subsidiary) ("Guarantors"). All other subsidiaries of the Company, either direct or indirect, are non-guarantors and do not guarantee the 2024 Notes, 2025 Notes, 2026 Notes or 2028 Notes ("Non-Guarantors"). The Guarantors also guarantee certain other debt. These condensed consolidating financial statements have been prepared from the Company's financial information on the same basis of accounting as the consolidated financial statements. Interest expense and certain other costs are partially allocated to all of the subsidiaries of the Company. Goodwill and other intangible assets have been allocated to the subsidiaries based on management's estimates. CONDENSED CONSOLIDATING BALANCE SHEETS September 27, 2019 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated ASSETS Current Assets: Cash and cash equivalents $ 5 $ 33,510 $ 40,544 $ 172,584 $ — $ 246,643 Receivables — 1,966 522,627 1,282,371 — 1,806,964 Inventories — 15,804 301,091 94,424 — 411,319 Prepayments and other current assets — 27,164 82,666 83,631 — 193,461 Total current assets 5 78,444 946,928 1,633,010 — 2,658,387 Property and Equipment, net — 43,329 1,784,410 354,023 — 2,181,762 Goodwill — 173,104 4,694,549 651,147 — 5,518,800 Investment in and Advances to Subsidiaries 3,320,042 6,649,119 — 717,228 (10,686,389 ) — Other Intangible Assets — 29,684 1,819,315 184,567 — 2,033,566 Other Assets — 20,382 979,350 346,076 (2,002 ) 1,343,806 $ 3,320,047 $ 6,994,062 $ 10,224,552 $ 3,886,051 $ (10,688,391 ) $ 13,736,321 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Current maturities of long-term borrowings $ — $ 6,256 $ 27,924 $ 35,748 $ — $ 69,928 Accounts payable — 127,640 507,903 363,974 — 999,517 Accrued expenses and other current liabilities — 241,523 1,030,074 364,168 88 1,635,853 Total current liabilities — 375,419 1,565,901 763,890 88 2,705,298 Long-term Borrowings — 6,090,487 82,394 439,358 — 6,612,239 Deferred Income Taxes and Other Noncurrent Liabilities — 380,453 569,409 138,960 — 1,088,822 Intercompany Payable — — 4,187,591 726,464 (4,914,055 ) — Redeemable Noncontrolling Interest — — 9,915 — — 9,915 Total Stockholders' Equity 3,320,047 147,703 3,809,342 1,817,379 (5,774,424 ) 3,320,047 $ 3,320,047 $ 6,994,062 $ 10,224,552 $ 3,886,051 $ (10,688,391 ) $ 13,736,321 CONDENSED CONSOLIDATING BALANCE SHEETS September 28, 2018 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated ASSETS Current Assets: Cash and cash equivalents $ 5 $ 50,716 $ 29,844 $ 134,460 $ — $ 215,025 Receivables — 1,038 443,599 1,345,796 — 1,790,433 Inventories — 15,857 592,259 116,686 — 724,802 Prepayments and other current assets — 21,411 86,100 63,654 — 171,165 Total current assets 5 89,022 1,151,802 1,660,596 — 2,901,425 Property and Equipment, net — 28,341 1,013,523 336,230 — 1,378,094 Goodwill — 173,104 4,783,547 653,917 — 5,610,568 Investment in and Advances to Subsidiaries 3,029,553 7,441,605 90,049 844,245 (11,405,452 ) — Other Intangible Assets — 29,684 1,919,795 187,365 — 2,136,844 Other Assets — 100,754 1,264,976 329,443 (2,002 ) 1,693,171 $ 3,029,558 $ 7,862,510 $ 10,223,692 $ 4,011,796 $ (11,407,454 ) $ 13,720,102 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Current maturities of long-term borrowings $ — $ — $ 26,564 $ 4,343 $ — $ 30,907 Accounts payable — 128,460 483,606 406,854 — 1,018,920 Accrued expenses and other current liabilities — 205,807 926,794 307,643 88 1,440,332 Total current liabilities — 334,267 1,436,964 718,840 88 2,490,159 Long-term Borrowings — 6,651,110 82,097 479,870 — 7,213,077 Deferred Income Taxes and Other Noncurrent Liabilities — 432,583 466,331 78,301 — 977,215 Intercompany Payable — — 4,827,084 955,407 (5,782,491 ) — Redeemable Noncontrolling Interest — — 10,093 — — 10,093 Total Stockholders' Equity 3,029,558 444,550 3,401,123 1,779,378 (5,625,051 ) 3,029,558 $ 3,029,558 $ 7,862,510 $ 10,223,692 $ 4,011,796 $ (11,407,454 ) $ 13,720,102 CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME For the year ended September 27, 2019 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated Revenue $ — $ 1,062,655 $ 10,653,013 $ 4,511,673 $ — $ 16,227,341 Costs and Expenses: Cost of services provided — 981,661 9,362,232 4,188,769 — 14,532,662 Depreciation and amortization — 16,377 473,833 102,363 — 592,573 Selling and general corporate expenses — 162,963 176,714 27,579 — 367,256 Gain on sale of Healthcare Technologies — — (156,309 ) — — (156,309 ) Interest and other financing costs, net — 316,120 3,531 15,336 — 334,987 Expense allocations — (315,432 ) 274,501 40,931 — — — 1,161,689 10,134,502 4,374,978 — 15,671,169 Income (Loss) before Income Taxes — (99,034 ) 518,511 136,695 — 556,172 Provision (Benefit) for Income Taxes — (38,388 ) 109,144 36,950 — 107,706 Equity in Net Income of Subsidiaries 448,549 — — — (448,549 ) — Net income (loss) 448,549 (60,646 ) 409,367 99,745 (448,549 ) 448,466 Less: Net loss attributable to noncontrolling interest — — (83 ) — — (83 ) Net income (loss) attributable to Aramark stockholders 448,549 (60,646 ) 409,450 99,745 (448,549 ) 448,549 Other comprehensive income (loss), net of tax (125,742 ) (71,282 ) (553 ) (121,505 ) 193,340 (125,742 ) Comprehensive income (loss) attributable to Aramark stockholders $ 322,807 $ (131,928 ) $ 408,897 $ (21,760 ) $ (255,209 ) $ 322,807 CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME For the year ended September 28, 2018 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated Revenue $ — $ 1,027,573 $ 10,432,088 $ 4,329,972 $ — $ 15,789,633 Costs and Expenses: Cost of services provided — 848,739 9,132,991 4,016,181 — 13,997,911 Depreciation and amortization — 19,466 483,106 93,610 — 596,182 Selling and general corporate expenses — 195,093 158,064 23,972 — 377,129 Interest and other financing costs, net — 329,027 266 17,242 — 346,535 Expense allocations — (374,970 ) 353,628 21,342 — — — 1,017,355 10,128,055 4,172,347 — 15,317,757 Income before Income Taxes — 10,218 304,033 157,625 — 471,876 Provision (Benefit) for Income Taxes — (3,521 ) (143,452 ) 50,409 — (96,564 ) Equity in Net Income of Subsidiaries 567,885 — — — (567,885 ) — Net income 567,885 13,739 447,485 107,216 (567,885 ) 568,440 Less: Net income attributable to noncontrolling interest — — 555 — — 555 Net income attributable to Aramark stockholders 567,885 13,739 446,930 107,216 (567,885 ) 567,885 Other comprehensive income (loss), net of tax 32,537 43,686 3,178 (36,776 ) (10,088 ) 32,537 Comprehensive income attributable to Aramark stockholders $ 600,422 $ 57,425 $ 450,108 $ 70,440 $ (577,973 ) $ 600,422 CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME For the year ended September 29, 2017 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated Revenue $ — $ 1,041,490 $ 9,708,157 $ 3,854,765 $ — $ 14,604,412 Costs and Expenses: Cost of services provided — 941,031 8,507,705 3,546,667 — 12,995,403 Depreciation and amortization — 17,502 416,979 73,731 — 508,212 Selling and general corporate expenses — 140,305 138,304 20,561 — 299,170 Interest and other financing costs, net — 273,405 (3,196 ) 10,776 — 280,985 Expense allocations — (348,042 ) 318,199 29,843 — — — 1,024,201 9,377,991 3,681,578 — 14,083,770 Income Before Income Taxes — 17,289 330,166 173,187 — 520,642 Provision for Income Taxes — 5,139 98,144 43,172 — 146,455 Equity in Net Income of Subsidiaries 373,923 — — — (373,923 ) — Net income 373,923 12,150 232,022 130,015 (373,923 ) 374,187 Less: Net income attributable to noncontrolling interest — — 264 — — 264 Net income attributable to Aramark stockholders 373,923 12,150 231,758 130,015 (373,923 ) 373,923 Other comprehensive income, net of tax 57,023 35,667 431 80,204 (116,302 ) 57,023 Comprehensive income attributable to Aramark stockholders $ 430,946 $ 47,817 $ 232,189 $ 210,219 $ (490,225 ) $ 430,946 CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS For the year ended September 27, 2019 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated Net cash provided by (used in) operating activities $ — $ (47,231 ) $ 757,832 $ 290,539 $ (16,913 ) $ 984,227 Cash flows from investing activities: Purchases of property and equipment and other — (12,160 ) (414,017 ) (76,913 ) — (503,090 ) Disposals of property and equipment — 6,644 6,665 4,562 — 17,871 Proceeds from divestiture — — 293,711 — — 293,711 Acquisitions of businesses, net of cash acquired — — (23,028 ) (21,835 ) — (44,863 ) Proceeds from government agencies related to property and equipment — — 23,025 — — 23,025 Other investing activities — (356 ) 3,677 504 — 3,825 Net cash used in investing activities — (5,872 ) (109,967 ) (93,682 ) — (209,521 ) Cash flows from financing activities: Proceeds from long-term borrowings — — — 77,630 — 77,630 Payments of long-term borrowings — (545,809 ) (34,431 ) (74,320 ) — (654,560 ) Payments of dividends — (108,439 ) — — — (108,439 ) Proceeds from issuance of common stock — 39,087 — — — 39,087 Repurchase of common stock — (50,000 ) — — — (50,000 ) Other financing activities — (36,305 ) (2,192 ) (113 ) — (38,610 ) Change in intercompany, net — 737,363 (600,542 ) (153,734 ) 16,913 — Net cash provided by (used in) financing activities — 35,897 (637,165 ) (150,537 ) 16,913 (734,892 ) Effect of foreign exchange rates on cash and cash equivalents — — — (8,196 ) — (8,196 ) Decrease (increase) in cash and cash equivalents — (17,206 ) 10,700 38,124 — 31,618 Cash and cash equivalents, beginning of period 5 50,716 29,844 134,460 — 215,025 Cash and cash equivalents, end of period $ 5 $ 33,510 $ 40,544 $ 172,584 $ — $ 246,643 CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS For the year ended September 28, 2018 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated Net cash provided by operating activities $ — $ 111,541 $ 690,218 $ 315,703 $ (65,587 ) $ 1,051,875 Cash flows from investing activities: Purchases of property and equipment other — (13,133 ) (532,923 ) (82,548 ) — (628,604 ) Disposals of property and equipment — 2,252 4,301 3,938 — 10,491 Acquisitions of businesses, net of cash acquired — (2,381,800 ) 244,581 (103,065 ) — (2,240,284 ) Other investing activities — (3,095 ) 328 (4,112 ) — (6,879 ) Net cash used in investing activities — (2,395,776 ) (283,713 ) (185,787 ) — (2,865,276 ) Cash flows from financing activities: Proceeds from long-term borrowings — 3,012,072 — 165,241 — 3,177,313 Payments of long-term borrowings — (833,854 ) (28,142 ) (111,693 ) — (973,689 ) Net change in funding under the Receivables Facility — — — (254,200 ) — (254,200 ) Payments of dividends — (103,115 ) — — — (103,115 ) Proceeds from issuance of common stock — 21,507 — — — 21,507 Repurchase of common stock — (24,410 ) — — — (24,410 ) Other financing activities — (45,905 ) (2,958 ) (390 ) — (49,253 ) Change in intercompany, net — 197,144 (383,074 ) 120,343 65,587 — Net cash provided by (used in) financing activities — 2,223,439 (414,174 ) (80,699 ) 65,587 1,794,153 Effect of foreign exchange rates on cash and cash equivalents — — — (4,524 ) — (4,524 ) (Decrease) increase in cash and cash equivalents — (60,796 ) (7,669 ) 44,693 — (23,772 ) Cash and cash equivalents, beginning of period 5 111,512 37,513 89,767 — 238,797 Cash and cash equivalents, end of period $ 5 $ 50,716 $ 29,844 $ 134,460 $ — $ 215,025 CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS For the year ended September 29, 2017 (in thousands) Aramark (Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated Net cash provided by operating activities $ — $ 261,282 $ 779,801 $ 200,018 $ (188,275 ) $ 1,052,826 Cash flows from investing activities: Purchases of property and equipment and other — (20,939 ) (443,262 ) (88,528 ) — (552,729 ) Disposals of property and equipment — 494 14,780 3,632 — 18,906 Acquisitions of businesses, net of cash acquired — — (37,130 ) (104,992 ) — (142,122 ) Other investing activities — (69,401 ) 36,946 29,916 — (2,539 ) Net cash used in investing activities — (89,846 ) (428,666 ) (159,972 ) — (678,484 ) Cash flows from financing activities: Proceeds from long-term borrowings — 3,451,164 — 400,253 — 3,851,417 Payments of long-term borrowings — (3,572,268 ) (19,851 ) (319,873 ) — (3,911,992 ) Net change in funding under the Receivables Facility — — — (13,800 ) — (13,800 ) Payments of dividends — (100,813 ) — — — (100,813 ) Proceeds from issuance of common stock — 28,779 — — — 28,779 Repurchase of common stock — (100,000 ) — — — (100,000 ) Other financing activities — (69,172 ) (2,973 ) 29,868 — (42,277 ) Change in intercompany, net — 254,536 (322,142 ) (120,669 ) 188,275 — Net cash used in financing activities — (107,774 ) (344,966 ) (24,221 ) 188,275 (288,686 ) Effect of foreign exchange rates on cash and cash equivalents — — — 561 — 561 Increase in cash and cash equivalents — 63,662 6,169 16,386 — 86,217 Cash and cash equivalents, beginning of period 5 47,850 31,344 73,381 — 152,580 Cash and cash equivalents, end of period $ 5 $ 111,512 $ 37,513 $ 89,767 $ — $ 238,797 |